Kevin Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kevin Liu has a total of 2 co-authors. Here are the top co-authors by number of shared publications:
- Abdul Aziz Aadam
Department of Medicine, Division of Gastroenterology and Hepatology, Feinberg School of Medicine, Kenneth C. Griffin Esophageal Center of Northwestern Medicine, Northwestern University, Chicago, IL, USA
1 shared publication - Leila Kia
Division of Gastroenterology and Hepatology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
1 shared publication
Latest Publications
- 1 November 2019
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 17 (12) , e139-E139
Mycophenolate Mofetil–Induced Esophagitis
- 1 November 2019
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 17 (12) , e139-E139
Mycophenolate Mofetil–Induced Esophagitis
- 4 May 2019
- Published by Wiley in Journal of Surgical Oncology
- Vol. 120 (1) , 57-64
Endoscopic palliation of biliary obstruction
Advanced pancreaticobiliary malignancy tends to be uncurable at presentation and causes significant morbidity for patients. Palliation for malignant biliary obstruction should be minimally invasive, cost‐effective, and aim to improve quality of life of patients. Strategies of endoscopic palliation of malignant biliary obstruction can differ based on sites and degree of biliary obstruction with complex decisions of optimal stent type and placement that involve conscientious planning by a multidisciplinary team.
- 4 May 2019
- Published by Wiley in Journal of Surgical Oncology
- Vol. 120 (1) , 57-64
Endoscopic palliation of biliary obstruction
Advanced pancreaticobiliary malignancy tends to be uncurable at presentation and causes significant morbidity for patients. Palliation for malignant biliary obstruction should be minimally invasive, cost‐effective, and aim to improve quality of life of patients. Strategies of endoscopic palliation of malignant biliary obstruction can differ based on sites and degree of biliary obstruction with complex decisions of optimal stent type and placement that involve conscientious planning by a multidisciplinary team.